An antagonist of NAADP receptors
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

trans-Ned-19

Item No. 17527

Technical Information
Formal Name
(1R,3S)-1-[3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
CAS Number
1354235-96-3
Molecular Formula
C30H31FN4O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 10 mg/mlDMF:PBS (pH 7.2) (1:1): 0.5 mg/mlDMSO: 2 mg/ml
λmax
222, 272 nm
SMILES
FC1=CC=CC=C1N2CCN(CC3=CC([C@H]4N[C@H](C(O)=O)CC5=C4NC6=C5C=CC=C6)=CC=C3OC)CC2
InChi Code
InChI=1S/C30H31FN4O3/c1-38-27-11-10-19(16-20(27)18-34-12-14-35(15-13-34)26-9-5-3-7-23(26)31)28-29-22(17-25(33-28)30(36)37)21-6-2-4-8-24(21)32-29/h2-11,16,25,28,32-33H,12-15,17-18H2,1H3,(H,36,37)/t25-,28+/m0/s1
InChi Key
FUHCEERDBRGPQZ-LBNVMWSVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Nicotinic acid adenine dinucleotide phosphate (NAADP) is a dinucleotide second messenger that triggers the release of calcium from lysosomes and related cellular compartments.1 trans-Ned-19 is a structural analog of NAADP that blocks NAADP-dependent calcium release (IC50 = 6 nM) as well as NAADP binding to sea urchin egg homogenate (IC50 = 0.4 nM).2 The trans form of Ned-19 is significantly more potent than the cis isomer in both assays.2 Ned-19 does not affect either IP3-mediated calcium release or cyclic ADP-ribose-mediated calcium release.2 It directly binds NAADP receptors on lysosomes in mouse pancreatic beta cells and competitively antagonizes activation by NAADP.2,3 It inhibits glucose-induced calcium oscillations in pancreatic islets and insulin-induced calcium increases in 3T3-L1 adipocytes.2,4 Ned-19 also blocks calcium signaling induced by endothelin-1 or norepinephrine in renal afferent arterioles.5 Ned-19 dose-dependently reduces infection of host cells by Ebola virus.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lam, A.K.M., and Galione, A. The endoplasmic reticulum and junctional membrane communication during calcium signaling. Biochim. Biophys. Acta 1833(11), 2542-2559 (2013).

    2. Naylor, E., Arredouani, A., Vasudevan, S.R., et alIdentification of a chemical probe for NAADP by virtual screening. Nat. Chem. Biol. 5(4), 220-226 (2009).

    3. Rosen, D., Lewis, A.M., Mizote, A., et alAnalogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist Ned-19 indicate two binding sites on the NAADP receptor. The Journal of Biological Chemisty 284(50), 34930-34934 (2009).

    4. Song, E.K., Lee, Y.R., Kim, Y.R., et alNAADP mediates insulin-stimulated glucose uptake and insulin sensitization by PPARγ in adipocytes. Cell Rep. 2(6), 1607-1619 (2012).

    5. Sakurai, Y., Kolokoltsov, A.A., Chen, C.C., et alTwo-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347(6225), 995-998 (2015).

    6. Thai, T.L., Churchill, G.C., and Arendshorst, W.J. NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am. J. Physiol. Renal. Physiol. 297(2), F510-F516 (2009).